Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Abstract 533: A study of sequencing circulating cell free DNA from lung cancer patients

Zhigang Kang, Liang Cao

Cancer Res (2022) 82 (12_Supplement): 533.

https://doi.org/10.1158/1538-7445.AM2022-533

Published: 15 June 2022

View article titled, Abstract 533: A study of sequencing circulating cell free DNA from lung cancer patients

Journal Articles

Abstract 3330: Circulating HPV DNA as a biomarker for metastatic cervical cancer detection, genotyping and monitoring

Zhigang Kang, Sanja Stevanović, Christian Hinrichs, Liang Cao

Cancer Res (2019) 79 (13_Supplement): 3330.

https://doi.org/10.1158/1538-7445.AM2019-3330

Published: 01 July 2019

View article titled, Abstract 3330: Circulating HPV DNA as a biomarker for metastatic cervical cancer detection, genotyping and monitoring

Journal Articles

Abstract 1382: Megakaryocyte potentiating factor as a predictive biomarker for therapies against malignant mesothelioma

Liang Cao, Yunkai Yu, Anish. Thomas, Jingli Zhang, Masanori Onda, Paul Meltzer, Raffit Hassan, Ira Pastan

Cancer Res (2019) 79 (13_Supplement): 1382.

https://doi.org/10.1158/1538-7445.AM2019-1382

Published: 01 July 2019

View article titled, Abstract 1382: Megakaryocyte potentiating factor as a predictive biomarker for therapies against malignant mesothelioma

Journal Articles

Abstract 292: PTC596 combination therapy for sarcoma

Marla Weetall, Art Branstrom, John Baird, Liang Cao, Josephine Sheedy, Kylie O'Keefe, Matthew Ingham, Gary K. Schwartz, Robert Spiegel, Edward O'Mara

Cancer Res (2019) 79 (13_Supplement): 292.

https://doi.org/10.1158/1538-7445.AM2019-292

Published: 01 July 2019

View article titled, Abstract 292: PTC596 combination therapy for sarcoma

Journal Articles

Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non–Small Cell Lung Cancer

Mingxiang Ye, Yong Zhang, Xinxin Zhang, Jianbin Zhang, Pengyu Jing, Liang Cao, Nan Li, Xia Li, Libo Yao, Jian Zhang, Jian Zhang

Cancer Res (2017) 77 (13): 3527–3539.

https://doi.org/10.1158/0008-5472.CAN-16-3470

Published: 02 July 2017

View article titled, Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non–Small Cell Lung Cancer

Includes: Supplementary data

Journal Articles

Abstract 3813: MPF as a monitoring biomarker for a mesothelin-targeted therapy against malignant mesothelioma and other cancer

Yunkai Yu, Raffit Hassan, Jingli Zhang, Masanori Onda, Ira Pastan, Liang Cao

Cancer Res (2017) 77 (13_Supplement): 3813.

https://doi.org/10.1158/1538-7445.AM2017-3813

Published: 01 July 2017

View article titled, Abstract 3813: MPF as a monitoring biomarker for a mesothelin-targeted therapy against malignant mesothelioma and other cancer

Journal Articles

Abstract CT080: Pharmacokinetic and pharmacodynamic analysis of M7824, a dual anti-PD-L1 and TGFβ TRAP molecule, in the first-in-human phase I dose escalation study

Liang Cao, Zhigang Kang, Linghui Li, Julius Strauss, Isabelle Dussault, James Gulley

Cancer Res (2017) 77 (13_Supplement): CT080.

https://doi.org/10.1158/1538-7445.AM2017-CT080

Published: 01 July 2017

View article titled, Abstract CT080: Pharmacokinetic and pharmacodynamic analysis of M7824, a dual anti-PD-L1 and TGFβ TRAP molecule, in the first-in-human phase I dose escalation study

Journal Articles

Abstract 4658: Inflammatory based diagnostic markers of lung cancer in African Americans

Claire L. Meaney, Khadijah A. Mitchell, Adriana Zingone, Derek Brown, Wei Tang, Yunkai Yu, Liang Cao, Angela S. Wenzlaff, Ann G. Schwartz, Brid M. Ryan

Cancer Res (2017) 77 (13_Supplement): 4658.

https://doi.org/10.1158/1538-7445.AM2017-4658

Published: 01 July 2017

View article titled, Abstract 4658: Inflammatory based diagnostic markers of lung cancer in African Americans

Journal Articles

Abstract 3406: The identification of serum cytokine inflammatory markers as classifiers of lung cancer mortality for stage I lung adenocarcinoma: a retrospective cohort study

Claire L. Meaney, Adriana Zingone, Derek Brown, Yunkai Yu, Liang Cao, Brid M. Ryan

Cancer Res (2016) 76 (14_Supplement): 3406.

https://doi.org/10.1158/1538-7445.AM2016-3406

Published: 15 July 2016

View article titled, Abstract 3406: The identification of serum cytokine inflammatory markers as classifiers of lung cancer mortality for stage I lung adenocarcinoma: a retrospective cohort study

Journal Articles

Abstract 2048: Pharmacodynamic biomarker studies of TRC105 anti-endoglin (CD105) antibody revealed anti-angiogenic activity associated with CD105 depletion

Liang Cao, Fatima Karzai, Andrea Apolo, Ravi Madan, Yunkai Yu, James Gulley, William Figg, William Dahut

Cancer Res (2016) 76 (14_Supplement): 2048.

https://doi.org/10.1158/1538-7445.AM2016-2048

Published: 15 July 2016

View article titled, Abstract 2048: Pharmacodynamic biomarker studies of TRC105 anti-endoglin (CD105) antibody revealed anti-angiogenic activity associated with CD105 depletion

Journal Articles

Abstract 366: A novel transcript variant of androgen receptor identified in circulating tumor cells from castration-resistant prostate cancer patients as a potentially prognostic biomarker

Zhigang Kang, Avani Shah, Yunkai Yu, Yuelin Zhu, Ali Asgar Bhagat, Kyra Zhao, Andrew Wu, James Gao, Ravi Madan, James Gulley, William Dahut, Paul Meltzer, Liang Cao

Cancer Res (2015) 75 (15_Supplement): 366.

https://doi.org/10.1158/1538-7445.AM2015-366

Published: 01 August 2015

View article titled, Abstract 366: A novel transcript variant of androgen receptor identified in circulating tumor cells from castration-resistant prostate cancer patients as a potentially prognostic biomarker

Journal Articles

Abstract 2917: Caspase-8 expression is predictive of tumor response to death receptor 5 agonist antibody conatumumab in Ewing's sarcoma

Zhigang Kang, D Seth Goldstein, Yunkai Yu, Paul S. Meltzer, David M. Loeb, Liang Cao

Cancer Res (2015) 75 (15_Supplement): 2917.

https://doi.org/10.1158/1538-7445.AM2015-2917

Published: 01 August 2015

View article titled, Abstract 2917: Caspase-8 expression is predictive of tumor response to death receptor 5 agonist antibody conatumumab in Ewing's sarcoma

Journal Articles

Abstract 1719: Down-regulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma

Zhigang Kang, Yunkai Yu, Yuelin J. Zhu, Lee Helman, Paul Meltzer, Liang Cao

Cancer Res (2014) 74 (19_Supplement): 1719.

https://doi.org/10.1158/1538-7445.AM2014-1719

Published: 01 October 2014

View article titled, Abstract 1719: Down-regulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma

Journal Articles

Abstract 4815: A novel AR splice variant identified in circulating tumor cells from castration-resistant prostate cancer patient blood as a potentially prognostic biomarker

Zhigang Kang, Yunkai Yu, Liang Cao, Paul S. Meltzer, Yuelin Zhu, Avan Shah, James Gulley, William Duht, Ravi Madan, Ali Bhagat, Kyra Zhao

Cancer Res (2014) 74 (19_Supplement): 4815.

https://doi.org/10.1158/1538-7445.AM2014-4815

Published: 01 October 2014

View article titled, Abstract 4815: A novel AR splice variant identified in circulating tumor cells from castration-resistant prostate cancer patient blood as a potentially prognostic biomarker

Journal Articles

Abstract 736: Development of a novel circulating tumor cell technology for cancer predictive biomarker analysis.

Zhigang Kang, William Dahut, James Gulley, Yunkai Yu, Paul S. Meltzer, Liang Cao

Cancer Res (2013) 73 (8_Supplement): 736.

https://doi.org/10.1158/1538-7445.AM2013-736

Published: 15 April 2013

View article titled, Abstract 736: Development of a novel circulating tumor cell technology for cancer predictive biomarker analysis.

Journal Articles

Abstract 4449: Resistance to insulin-like growth factor 1 receptor antibody associated with downregulated IGFBP2.

Yunkai Yu, Zhigang Kang, Lee Helman, Paul Meltzer, Liang Cao

Cancer Res (2013) 73 (8_Supplement): 4449.

https://doi.org/10.1158/1538-7445.AM2013-4449

Published: 15 April 2013

View article titled, Abstract 4449: Resistance to insulin-like growth factor 1 receptor antibody associated with downregulated IGFBP2.

Journal Articles

Abstract 254: Genome-wide shRNA screening identifies candidate proteins modulating the extrinsic apoptotic pathway

Zhigang Kang, Liang Cao

Cancer Res (2012) 72 (8_Supplement): 254.

https://doi.org/10.1158/1538-7445.AM2012-254

Published: 15 April 2012

View article titled, Abstract 254: Genome-wide shRNA screening identifies candidate proteins modulating the extrinsic apoptotic pathway

Journal Articles

Abstract 651: Insulin-like growth factor 1 receptor antibody induces rhabdomyosarcoma cell death via a process involving AKT and Bcl-xL

Linnia Mayeenuddin, Yunkai Yu, Zhigang Kang, Lee Helman, Liang Cao

Cancer Res (2011) 71 (8_Supplement): 651.

https://doi.org/10.1158/1538-7445.AM2011-651

Published: 15 April 2011

View article titled, Abstract 651: Insulin-like growth factor 1 receptor antibody induces rhabdomyosarcoma cell death via a process involving AKT and Bcl-xL

Journal Articles

Abstract 646: Anti-tumor efficacy of IMC-A12, a fully human anti-insulin like growth factor 1 receptor (IGF-1R) antibody, against malignant mesothelioma (MM)

Neetu Kalra, Jingli Zhang, Yunkai Yu, Mitchell Ho, Liang Cao, Raffit Hassan

Cancer Res (2011) 71 (8_Supplement): 646.

https://doi.org/10.1158/1538-7445.AM2011-646

Published: 15 April 2011

View article titled, Abstract 646: Anti-tumor efficacy of IMC-A12, a fully human anti-insulin like growth factor 1 receptor (IGF-1R) antibody, against malignant mesothelioma (MM)

Journal Articles

Abstract 4094: A human antibody to death receptor 5 has potent antitumor activity against rhabdomyosarcoma with the expression of caspase-8 predictive of response

Zhigang Kang, Junjie Chen, Yunkai Yu, Baolin Zhang, Liang Cao

Cancer Res (2011) 71 (8_Supplement): 4094.

https://doi.org/10.1158/1538-7445.AM2011-4094

Published: 15 April 2011

View article titled, Abstract 4094: A human antibody to death receptor 5 has potent antitumor activity against rhabdomyosarcoma with the expression of caspase-8 predictive of response

NARROW

Abstract 533: A study of sequencing circulating cell free DNA from lung cancer patients

Abstract 3330: Circulating HPV DNA as a biomarker for metastatic cervical cancer detection, genotyping and monitoring

Abstract 1382: Megakaryocyte potentiating factor as a predictive biomarker for therapies against malignant mesothelioma

Abstract 292: PTC596 combination therapy for sarcoma

Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non–Small Cell Lung Cancer

Abstract 3813: MPF as a monitoring biomarker for a mesothelin-targeted therapy against malignant mesothelioma and other cancer

Abstract CT080: Pharmacokinetic and pharmacodynamic analysis of M7824, a dual anti-PD-L1 and TGFβ TRAP molecule, in the first-in-human phase I dose escalation study

Abstract 4658: Inflammatory based diagnostic markers of lung cancer in African Americans

Abstract 3406: The identification of serum cytokine inflammatory markers as classifiers of lung cancer mortality for stage I lung adenocarcinoma: a retrospective cohort study

Abstract 2048: Pharmacodynamic biomarker studies of TRC105 anti-endoglin (CD105) antibody revealed anti-angiogenic activity associated with CD105 depletion

Abstract 366: A novel transcript variant of androgen receptor identified in circulating tumor cells from castration-resistant prostate cancer patients as a potentially prognostic biomarker

Abstract 2917: Caspase-8 expression is predictive of tumor response to death receptor 5 agonist antibody conatumumab in Ewing's sarcoma

Abstract 1719: Down-regulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma

Abstract 4815: A novel AR splice variant identified in circulating tumor cells from castration-resistant prostate cancer patient blood as a potentially prognostic biomarker

Abstract 736: Development of a novel circulating tumor cell technology for cancer predictive biomarker analysis.

Abstract 4449: Resistance to insulin-like growth factor 1 receptor antibody associated with downregulated IGFBP2.

Abstract 254: Genome-wide shRNA screening identifies candidate proteins modulating the extrinsic apoptotic pathway

Abstract 651: Insulin-like growth factor 1 receptor antibody induces rhabdomyosarcoma cell death via a process involving AKT and Bcl-xL

Abstract 646: Anti-tumor efficacy of IMC-A12, a fully human anti-insulin like growth factor 1 receptor (IGF-1R) antibody, against malignant mesothelioma (MM)

Abstract 4094: A human antibody to death receptor 5 has potent antitumor activity against rhabdomyosarcoma with the expression of caspase-8 predictive of response

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only